Worth reading
39Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Neutral
Direction inferred from the company’s description.Scale
45000
sharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Issuance of Stock Options (Seventh Series Share Acquisition Rights) to Directors
Who receives how much
45,000 common shares (450 Share Acquisition Rights, 100 shares per right)
3 of the Company’s directors: 450 rights (45,000 shares)
The lower thin line represents the existing number of shares to which these shares will be added.
The share acquisition rights will be issued free of charge
Total issue value
No consideration
Terms of the stock acquisition rights
Exercise price
The closing price on the date of the Board of Directors’ resolution. The terms provide for adjustments in the event of a stock split or consolidation, or the issuance of certain shares, potential shares or similar instruments. No lower limit is specified.
Exercise period
From 20 November 2028 to 29 October 2036
Number of Stock Acquisition Rights
Total issued: 450 rights; unexercised balance: Not disclosed
Reason for acquisition without consideration
Corporate reorganization; loss of the holder’s status as a director, audit & supervisory board member or employee of the Company or its subsidiaries, with exceptions; criminal sanctions; competition; misconduct; damage to the Company’s reputation or credit; attachment or similar proceedings; breach of contract; grounds for disciplinary action; or breach of duties as a director or otherwise.
Categories and Number of Persons Covered
3 of the Company’s directors: 450 rights (45,000 shares)
Intended allottee's holding policy
Any transfer of these Share Acquisition Rights requires the approval of the Company’s Board of Directors.
Basis for determining the amount to be paid
The exercise price of the Share Acquisition Rights will be the closing price on the date of the Board of Directors’ resolution concerning the determination of the offering terms, or, if there is no closing price on that date, the closing price on the most recent trading day.
Procedures under the Corporate Code of Conduct
Implemented by Board of Directors’ resolution without shareholder approval. The Company explained that the terms are not particularly favourable because the rights are issued at no charge based on their fair value.
Impact on Business Performance
The stated purpose is to increase motivation to contribute to improved performance and increased corporate value over the medium to long term. Specific monetary impact: Not disclosed
| Item | Details |
|---|---|
| Type of issuance or disposal | Issuance of Stock Options (Seventh Series Share Acquisition Rights) to Directors |
| Number of shares to be issued or disposed of | 45,000 common shares (450 Share Acquisition Rights, 100 shares per right) |
| Issue price and disposal price | The share acquisition rights will be issued free of charge |
| Total issue value | No consideration |
| Intended allottee | 3 of the Company’s directors: 450 rights (45,000 shares) |
| Intended allottee's holding policy | Any transfer of these Share Acquisition Rights requires the approval of the Company’s Board of Directors. |
| Basis for determining the amount to be paid | The exercise price of the Share Acquisition Rights will be the closing price on the date of the Board of Directors’ resolution concerning the determination of the offering terms, or, if there is no closing price on that date, the closing price on the most recent trading day. |
| Exercise price | The closing price on the date of the Board of Directors’ resolution. The terms provide for adjustments in the event of a stock split or consolidation, or the issuance of certain shares, potential shares or similar instruments. No lower limit is specified. |
| Exercise period | From 20 November 2028 to 29 October 2036 |
| Number of Stock Acquisition Rights | Total issued: 450 rights; unexercised balance: Not disclosed |
| Reason for acquisition without consideration | Corporate reorganization; loss of the holder’s status as a director, audit & supervisory board member or employee of the Company or its subsidiaries, with exceptions; criminal sanctions; competition; misconduct; damage to the Company’s reputation or credit; attachment or similar proceedings; breach of contract; grounds for disciplinary action; or breach of duties as a director or otherwise. |
| Categories and Number of Persons Covered | 3 of the Company’s directors: 450 rights (45,000 shares) |
| Procedures under the Corporate Code of Conduct | Implemented by Board of Directors’ resolution without shareholder approval. The Company explained that the terms are not particularly favourable because the rights are issued at no charge based on their fair value. |
| Impact on Business Performance | The stated purpose is to increase motivation to contribute to improved performance and increased corporate value over the medium to long term. Specific monetary impact: Not disclosed |
Items this document does not state (14)
Amount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateDilution RateTotal number of issued sharesTransfer restriction periodConditions for lifting transfer restrictionsTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMost recent equity financingMajor shareholders after the offering
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To promote the sharing of value between directors and shareholders and increase directors’ motivation to contribute to improved performance and increased corporate value over the medium to long term.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.